Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening?
Apimeds shares are surging Thursday after its subsidiary MindWave Innovations announced a technology services agreement with AQUAE Holdings.
Stocks · News reference
Apimeds Pharmaceuticals shares are trading higher after the company announced its subsidiary, MindWave, signed a 12-month technology services agreement with AQUAE Holdings to deploy its MindChain infrastructure as the foundation of AQUAEChain.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Tumbles Over 100 Points; US Jobless Claims Fall to 197,000
U.S. stocks fell Thursday as tech slid; jobless claims beat estimates. Oil rose, while APUS surged 245% and BENF plunged 33%.
Apimeds Pharmaceuticals' MindWave Signs 12-Month Contract To Build Conservation Credit Platform For AQUAE, Plus 20% Credit Allocation